ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p715.xmlNCCN Guidelines Insights: Survivorship, Version 1.20162026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p715.pdf2026-04-18NCCN Guidelines Insights: Survivorship, Version 1.2016https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-pxxxii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-pxxxii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p708.xmlCytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p708.pdf2026-04-18Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangementhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p701.xmlAndrogen Deprivation Therapy for Advanced Prostate Cancer: Can Evolution Be Accelerated?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p701.pdf2026-04-18Androgen Deprivation Therapy for Advanced Prostate Cancer: Can Evolution Be Accelerated?https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p699.xmlDid the IRB Approve This?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p699.pdf2026-04-18Did the IRB Approve This?https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-plxii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-plxii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p727.xmlLongitudinal Analysis of Severe Anxiety Symptoms in the Last Year of Life Among Patients With Advanced Cancer: Relationships With Proximity to Death, Burden, and Social Support2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p727.pdf2026-04-18Longitudinal Analysis of Severe Anxiety Symptoms in the Last Year of Life Among Patients With Advanced Cancer: Relationships With Proximity to Death, Burden, and Social Supporthttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p741.xmlIntegrating Palliative Care in Pediatric Oncology: Evidence for an Evolving Paradigm for Comprehensive Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p741.pdf2026-04-18Integrating Palliative Care in Pediatric Oncology: Evidence for an Evolving Paradigm for Comprehensive Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p735.xmlReadability of Online Patient Educational Resources Found on NCI-Designated Cancer Center Web Sites2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p735.pdf2026-04-18Readability of Online Patient Educational Resources Found on NCI-Designated Cancer Center Web Siteshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p749.xmlDifferences in Patient Screening Mammography Rates Associated With Internist Gender and Level of Training and Change Following the 2009 U.S. Preventive Services Task Force Guidelines2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p749.pdf2026-04-18Differences in Patient Screening Mammography Rates Associated With Internist Gender and Level of Training and Change Following the 2009 U.S. Preventive Services Task Force Guidelineshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p758.xmlSoft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p758.pdf2026-04-18Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p809.xmlPopulation-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p809.pdf2026-04-18Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Timehttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p795.xmlThe Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p795.pdf2026-04-18The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling?https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p787.xmlHow Do We Make Clinical Molecular Testing for Cancer Standard of Care for Pathology Departments?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/6/article-p787.pdf2026-04-18How Do We Make Clinical Molecular Testing for Cancer Standard of Care for Pathology Departments?